Stroke Alert July 2026
Jul 16, 2026 · 1 hr 11 min · 6 segments
On Episode 66 of the *Stroke Alert* Podcast, host Dr. Negar Asdaghi highlights two articles from the July 2026 issue of *Stroke*: "…
Jul 16, 2026 · 1 hr 11 min · 6 segments
On Episode 66 of the *Stroke Alert* Podcast, host Dr. Negar Asdaghi highlights two articles from the July 2026 issue of *Stroke*: "…
Diana Aguiar de SousaGuestWhat is the optimal duration of anticoagulation in patients with idiopathic cerebral venous sinus thrombosis? What are the main predictors of hematoma expansion in patients with anticoagulant-associated intracerebral hemorrhage? And finally, are GLP-1 receptor agonists simply diabetic and weight loss medications, or are they emerging as targeted vascular preventative therapies? We'll tackle these questions in today's podcast, answer a few, and create a lot more.
You're listening to the Stroke Alert podcast because this, without a doubt, is the best in stroke.
I'm a professor of neurology at the University of Miami Miller School of Medicine and your host for the monthly Stroke Alert podcast.
Read the full transcript.
Create an account to read the whole episode, search across every transcript, and follow the shows you care about.
What is the optimal duration of anticoagulation in patients with idiopathic cerebral venous sinus thrombosis? What are the main predictors of hematoma expansion in patients with anticoagulant-associated intracerebral hemorrhage? And finally, are GLP-1 receptor agonists simply diabetic and weight loss medications, or are they emerging as targeted vascular preventative therapies? We'll tackle these questions in today's podcast, answer a few, and create a lot more.
You're listening to the Stroke Alert podcast because this, without a doubt, is the best in stroke.
I'm a professor of neurology at the University of Miami Miller School of Medicine and your host for the monthly Stroke Alert podcast.
